Before searching for effective therapeutic strategies, however, we should analyze what determines FGF23/α-Klotho levels in cardiology patients; only a little information is available about FGF23/α-Klotho in non-CKD patients [15] as compared with patients in cardiology patients undergoing hemodialysis [16, 17]. The gene discussed is KL; the disease is chronic kidney disease.